B. Hunter

发表

Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.

A. Asgharian, L. Giorgi, B. Hunter, 2013, Clinical therapeutics.

A Double-blind Comparison of the Efficacy and Safety of Paroxetine and Imipramine in the Treatment of Depression with Dementia

R. Judge, B. Hunter, 1996, European Psychiatry.

The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days

V. Diehl, D. Dearnaley, H. Keizer, 1993, Journal of Cancer Research and Clinical Oncology.

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study.

X. Montalban, L. Kappos, H. Hartung, 2016, JAMA neurology.

A double‐blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia

C. Katona, B. Hunter, J. Bray, 1998 .

Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials.

D. Stein, M. Stein, Rajinder Kumar, 2002, The Journal of clinical psychiatry.

The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder

D. Stein, M. Stein, Rajinder Kumar, 2001, Psychopharmacology.

PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

A. Schapira, F. Stocchi, L. Giorgi, 2011, Movement disorders : official journal of the Movement Disorder Society.

A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.

D. Stein, R. Emsley, M. Berk, 1999, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Paroxetine in social anxiety disorder: A remission analysis

D. Stein, R. Oakes, B. Hunter, 2002, European Neuropsychopharmacology.

A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.

A. Ravindran, R. Judge, B. Hunter, 1997, The Journal of clinical psychiatry.

P.1.056 Depression associated with rheumatoid arthritis — comparison of paroxetine and amitriptyline

B. Hunter, 1997, European Neuropsychopharmacology.

Adjunctive ropinirole 24-hour prolonged release compared with adjunctive ropinirole immediate release in patients with advanced PD: results from a per-protocol analysis of the PREPARED study

A. Schapira, F. Stocchi, L. Giorgi, 2008 .

Adjunctive ropinirole 24-hour prolonged release compared with ropinirole immediate release in patients with advanced Parkinson's disease (PD): the PREPARED study

A. Schapira, F. Stocchi, L. Giorgi, 2008 .

On evaluation of symptom control in patients with advanced PD receiving adjunctive ropinirole 24-hour prolonged release versus ropinirole immediate release: results from the PREPARED study

A. Schapira, F. Stocchi, L. Giorgi, 2008 .

P-2-101 A double-blind, multicentre study in primary care comparing paroxetine and clomipramine in patients with depression with associated anxiety

B. Hunter, 1995, European Neuropsychopharmacology.